Skip to search formSkip to main contentSkip to account menu

nefiracetam

Known as: 1-Pyrrolidineacetamide, N-(2,6-dimethylphenyl)-2-oxo-, N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Central Nervous System AgentsNeuroprotective AgentsNootropic AgentsPsychotropic Drugs

Narrower (1)

DM 9384

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Antinociceptive effect of intrathecal loperamide: role of mu-opioid receptor and calcium channels.
2008
2008
CaM kinase II and protein kinase C activations mediate enhancement of long‐term potentiation by nefiracetam in the rat hippocampal CA1 region
Nefiracetam is a pyrrolidine‐related nootropic drug exhibiting various pharmacological actions such as cognitive‐enhancing effect… 
2007
2007
Nefiracetam Potentiates N-Methyl-d-aspartate (NMDA) Receptor Function via Protein Kinase C Activation and Reduces Magnesium Block of NMDA Receptor
Nicotinic acetylcholine receptors and N-methyl-d-aspartate (NMDA) receptors are known to be down-regulated in the brain of… 
2006
2006
Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds
2004
2004
Nefiracetam Attenuates Methamphetamine‐Induced Discriminative Stimulus Effects in Rats
Abstract: Nefiracetam has been reported to increase intracellular cyclic AMP levels and enhance calcium channel current. Since… 
2000
2000
Recovery of Diminished Mealtime-Associated Anticipatory Behavior by Aniracetam in Aged Rats
1994
1994
General pharmacological profile of the new cognition-enhancing agent nefiracetam.
The general pharmacological properties of a novel cognition-enhancing agent, nefiracetam (N-(2,6-dimethylphenyl)-2-(2-oxo-1… 
1993
1993
DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex.
1993
1993
Nefiracetam (DM‐9384) Preserves Hippocampal Neural Cell Adhesion Molecule‐Mediated Memory Consolidation Processes During Scopolamine Disruption of Passive Avoidance Training in the Rat
Abstract: Scopolamine (0.15 mg/kg), a muscarinic antagonist, when administered during training or at a discrete 6‐h posttraining… 
Highly Cited
1989
Highly Cited
1989
Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory were studied using four… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)